Table 1.
Subjects’ demographics and clinical characteristics according to the eye movement recording results
| All ALS patients(n = 62) | Normal eye movement recording(n = 17) | Abnormal eye movement recording(n = 45) | p value | |
|---|---|---|---|---|
| Gender (male: female) | 34: 28 | 10: 7 | 24: 21 | .69 |
| Mean age ± SD (years) | 60.5 ± 11 | 60 ± 10 | 61 ± 4 | .318 |
| Mean age of onset ± SD (years) | 56.6 ± 11 | 54 ± 17 | 57.6 ± 9 | .024 |
| Mean duration of disease ± SD (months) | 57 ± 60 | 54 ± 60 | 58 ± 54 | .879 |
| Disease onset (spinal: bulbar) | 55: 7 | 16: 1 | 39: 6 | .48 |
| ALSFRS-R score | 32 ± 9 | 33 | 31 | .166 |
| Riluzole intake | 59 (95.2%) | 16 | 43 | .814 |
ALS = amyotrophic lateral sclerosis
ALSFRS-R = revised amyotrophic lateral sclerosis functional rating scale
SD = standard deviation